A Prospective Study Comparing Induction Chemotherapy Followed By Chemoradiation Versus Chemoradiation Alone In Stage III Non Small Cell Lung Cancer

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021436

Enrollment

Registered

2019-09-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C348- Malignant neoplasm of overlappingsites of bronchus and lung

Interventions

Intervention1: induction chemo followed by concurrent chemoradiation: Two cycles of induction chemotherapy consisted of paclitaxel 200mg/m2 with car- boplatin (AUC-6) IV every 21 days. Following the c

Eligibility

Inclusion criteria

Inclusion criteria: non small cell lung cancer ecog 2

Exclusion criteria

Exclusion criteria: small cell lung cancer co morbidities

Design outcomes

Primary

Measure	Time frame
to assess difference in response between 2 armsTimepoint: 3months	—

Secondary

Measure	Time frame
Assess toxicity and survivalTimepoint: 1 year	—

Countries

India

Contacts

Public ContactPRITAM KUMAR SARDAR

Ipgmer Sskm Hospital

lekshmishenoi450@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026